THELMA Therapeutics Co., Ltd. (KOSE:A015540) announces a share repurchase program. Under the program, the company will repurchase up to 195,868 shares. The repurchased shares will be used as certificate of award.

The repurchase program is valid till January 6, 2023. As of January 4, 2023, the company had 0 shares within scope available for dividend and through other repurchase.